Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
federal funding
Biotech
ASH 2025 marked by ‘enduring activism’ and ‘cautious optimism’
While references to the Trump administration's attacks on science were prominent, an optimistic ASH was all about the data—and puppies.
Darren Incorvaia
Dec 9, 2025 3:15pm
Federal commission warns that US is losing innovative edge
Nov 25, 2025 3:47pm
NIH cuts disrupted hundreds of clinical trials, study finds
Nov 17, 2025 11:00am
MIT rejects Trump deal tying research money to certain demands
Oct 10, 2025 1:12pm
ARPA-H goes all in on in vivo cell therapy
Oct 8, 2025 4:04pm
Leader of NIAID fired in alleged whistleblower retaliation
Oct 3, 2025 12:12pm
